Clinical Trials Directory

Trials / Unknown

UnknownNCT05964777

rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder

Efficacy and Safety of rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder: a Randomized, Double-blind, Sham Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
First Affiliated Hospital of Zhejiang University · Academic / Other
Sex
All
Age
14 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Based on the individualized positioning technology of diffusion tensor imaging (DTI), the purpose of this study is to explore a new stimulation target and protocol for the treatment of bipolar disorder in remission through the repetitive transcranial magnetic stimulation(rTMS) and transcranial alternating current stimulation(tACS)under neuronavigation,verify whether there is abnormal functional connectivity and structural connections between the dorsolateral prefrontal cortex (dlpfc) and the dorsal anterior cingulate gyrus (dacc) related to cognitive impairment in bipolar disorder in remission, which will contribute to further understand the relevant neural pathway and mechanism.

Conditions

Interventions

TypeNameDescription
DEVICERepetitive Transcranial magnetic stimulation and transcranial alternating current stimulationwith the rapid development of neuroregulatory technology, rTMS and tACS have a profound impact on cognitive impairment. The damaged neural circuit of DLPFC-DACC may lead to impaired cognitive function in bipolar disorder.We used DTI imaging technology to calculate the DLPFC cortical region corresponding to the strongest point of dlpfc and DACC fiber connection as the stimulus site.Using high-frequency rTMS and high-precision tACS stimulation,thus affect the nerve ring pathway , thereby rapidly, effectively and safely improving cognitive impairment with bipolar disorder in remission.

Timeline

Start date
2023-07-01
Primary completion
2024-03-03
Completion
2024-04-04
First posted
2023-07-28
Last updated
2023-07-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05964777. Inclusion in this directory is not an endorsement.